[1] Zhang Z, Wang Y, Chen J, Tan Q, Xie C, Li C, et al. Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity[J]. Cancer Chemotherapy & Pharmacology, 2016, 78(6): 1-8. doi: 10.1007/s00280-016-3188-2.
[2] Yue X, Lan F M, Yang W, Yang Y, Han L, Zhang A, et al. Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells[J]. Brain Research, 2010, 1366: 27-37. doi: 10.1016/j.brainres.2010.10.032.
[3] Zhou Y H, Hu Y, Mayes D, Siegel E, Kim J G, Mathews M S, et al. PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A[J]. Journal of Neuro-Oncology, 2010, 96(2): 191-200. doi: 10.1007/s11060-009-9963-8.
[4] Gonzalez C, Sims J S, Hornstein N, Mela A, Garcia F, Lei L. Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors[J], 2014, 34(33): 10924-36. doi: 10.1523/JNEUROSCI.0084-14.2014.
[5] Yadav A K, Renfrow J J, Scholtens D M, Hehuang X, Duran G E, Claudia B, et al. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas[J]. Jama the Journal of the American Medical Association, 2009, 302(3): 276-89. doi: 10.1001/jama.2009.1022.
[6] Xu X, Cai N, Bao Z, You Y, Ji J, Liu N. Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo[J]. Journal of neuro-oncology, 2017, 135(3): 1-11. doi: 10.1007/s11060-017-2603-9.
[7] Williams D S. Glioblastoma multiforme[J]. J Insur Med, 2014, 44(1): 62-4. PMID: 25004601.
[8] Lin L, Liu A, Jg, Yu X, Qin L, Su D. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats[J]. Journal of Cardiovascular Pharmacology, 2007, 50(3): 327-332. doi: 10.1097/FJC.0b013e3180cbd0e7.
[9] Yang N, Zhao Y, Wang Z, Liu Y, Zhang Y. Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway[J]. Molecular Medicine Reports, 2016. doi: 10.3892/mmr.2016.6081.
[10] Zhang G, Wang Q, Jj, Zhang X, Tam S, Zheng Y. The anti-HIV-1 effect of scutellarin[J]. Biochemical & Biophysical Research Communications, 2005, 334(3): 812-816. doi: 10.1016/j.bbrc.2005.06.166.
[11] Qian L, Shen M, Tang H, Tang Y, Zhang L, Fu Y, et al. Synthesis and protective effect of scutellarein on focal cerebral ischemia/reperfusion in rats[J]. Molecules, 2012, 17(9): 10667-74. doi: 10.3390/molecules170910667.
[12] Yongsheng, Kwonghuat, Shaochin L. Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation[J]. Anticancer Research, 2009, 29(8): 3043-7. PMID: 19661313.
[13] Xu H, Zhang S. Scutellarin-Induced Apoptosis in HepG2 Hepatocellular Carcinoma Cells Via a STAT3 Pathway[J]. Phytotherapy Research, 2012, 27(10): 1524. doi: 10.1002/ptr.4892.
[14] Li H, Huang D, Gao Z, Chen Y, Zhang L, Zheng J. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin[J]. International Journal of Oncology, 2013, 42(5): 1674. doi: 10.3892/ijo.2013.1873.
[15] Kaneishi K. Lidocaine may be effective in alleviating physical symptoms in cancer patients[J]. J Palliat Med, 2014, 17(1): 8. doi: 10.1089/jpm.2013.0455.
[16] Bundscherer A C, Malsy M, Bitzinger D I, Wiese C H, Gruber M A, Graf B M. Effects of Lidocaine on HT-29 and SW480 Colon Cancer Cells In Vitro[J]. Anticancer Res, 2017, 37(4): 1941-1945. doi: 10.21873/anticanres.11534.
[17] Tat T, Jurj A, Selicean C, Pasca S, Ionescu D. Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment[J]. J buon, 2019, 24(1): 106-115. PMID: 30941958.
[18] Xing W, Chen D T, Pan J H, Chen Y H, Yan Y, Li Q, et al. Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo[J]. Anesthesiology, 2017, 126(5): 868-881. doi: 10.1097/ALN.0000000000001528.
[19] Freeman J, Crowley P D, Foley A G, Gallagher H C, Iwasaki M, Ma D, et al. Effect of Perioperative Lidocaine and Cisplatin on Metastasis in a Murine Model of Breast Cancer Surgery[J]. Anticancer Res, 2018, 38(10): 5599-5606. doi: 10.21873/anticanres.12894.
[20] Lirk P, Hollmann M W, Fleischer M, Weber N C, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro[J]. Br J Anaesth, 2014, 113 Suppl 1: i32-8. doi: 10.1093/bja/aeu201.
[21] Zhang H, Yang L, Zhu X, Zhu M, Sun Z, Cata J P, et al. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study[J]. Br J Anaesth, 2020, 125(2): 141-148. doi: 10.1016/j.bja.2020.03.034.
[22] He X Y, Xiong L L. C18H17NO6 and Its Combination with Scutellarin Suppress the Proliferation and Induce the Apoptosis of Human Glioma Cells via Upregulation of Fas-Associated Factor 1 Expression[J], 2019, 2019: 6821219. doi: 10.1155/2019/6821219.
[23] Han T, Li J, Xue J, Li H, Xu F, Cheng K, Li D, et al. Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation[J]. Eur J Med Chem, 2017, 135: 270-281. doi: 10.1016/j.ejmech.2017.03.020.
[24] Ke Y, Bao T, Wu X, Tang H, Wang Y, Ge J, et al. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity[J]. Biochemical and Biophysical Research Communications, 2016. doi: 10.1016/j.bbrc.2016.12.114.
[25] Wu W H, Chen T Y, Lu R W, Chen S T, Chang C C. Benzoxazinoids from Scoparia dulcis (sweet broomweed) with antiproliferative activity against the DU-145 human prostate cancer cell line[J]. Phytochemistry, 2012, 83(6): 110-115. doi: 10.1016/j.phytochem.2012.07.022.
[26] Franek K J, Zhou Z, Zhang W D, Chen W Y. In vitro studies of baicalin alone or in combination with Salvia miltiorrhiza extract as a potential anti-cancer agent[J]. Int J Oncol., 2005, 26(1): 217-224. PMID: 15586243.
[27] Feng Y, Zhang S, Tu J, Cao Z, Pan Y, Shang B, et al. Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells[J]. Leukemia & Lymphoma, 2012, 53(12): 2456. doi: 10.3109/10428194.2012.693177.
[28] Liu X, Ye F, Wu J, How B, Li W, Zhang D Y. Signaling proteins and pathways affected by flavonoids in leukemia cells[J]. Nutrition & Cancer-an International Journal, 2015, 67(2): 238-49. doi: 10.1080/01635581.2015.989372.
[29] Mamadalieva N Z, Herrmann F, El-Readi M Z, Tahrani A, Hamoud R, Egamberdieva D R, et al. Flavonoids in Scutellaria immaculata and S. ramosissima (Lamiaceae) and their biological activity[J]. Journal of Pharmacy & Pharmacology, 2011, 63(10): 1346-57. doi: 10.1111/j.2042-7158.2011.01336.x.
[30] Aslan E, Adem S. In Vitro Effects of Some Flavones on Human Pyruvate Kinase Isoenzyme M2[J]. J Biochem Mol Toxicol, 2015, 29(3): 109-113. doi: 10.1002/jbt.21673.
[31] Jurj A, Tomuleasa C, Tat T T, Berindan-Neagoe I, Vesa S V, Ionescu D C. Antiproliferative and Apoptotic Effects of Lidocaine on Human Hepatocarcinoma Cells. A preliminary study[J]. J Gastrointestin Liver Dis, 2017, 26(1): 45-50. doi: 10.15403/jgld.2014.1121.261.juj.
[32] Chamaraux-Tran T N, Mathelin C, Aprahamian M, Joshi G P, Tomasetto C, Diemunsch P, et al. Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An In Vitro and In Vivo Experimental Trial[J]. Anticancer Res, 2018, 38(1): 95-105. doi: 10.21873/anticanres.12196.
[33] Jakubowicz-Gil J, Badziul D, Langner E, Wertel I, Zajac A, Rzeski W. Temozolomide and sorafenib as programmed cell death inducers of human glioma cells[J]. Pharmacol Rep, 2017, 69(4): 779-787. doi: 10.1016/j.pharep.2017.03.008.
[34] Xie Z, Guo Z, Lei J, Yu J. Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA[J]. Thorac Cancer, 2019, 844: 9-16. doi: 10.1016/j.ejphar.2018.11.040.
[35] Sun C Y, Zhu Y, Li X F, Wang X Q, Tang L P, Su Z Q, et al. Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways[J]. Front Pharmacol, 2018, 9: 92. doi: 10.3389/fphar.2018.00092.
[36] Gao C, Zhou Y, Jiang Z, Zhao Y, Zhang D, Cong X, et al. Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells[J]. Oncol Rep, 2017, 38(3): 1491-1499. doi: 10.3892/or.2017.5850.
[37] Eskilsson E, Røsland G V, Solecki G, Wang Q, Harter P N, Graziani G, et al. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma[J]. Neuro Oncol, 2018, 20(6): 743-752. doi: 10.1093/neuonc/nox191.
[38] Saadeh F S, Mahfouz R, Assi H I. EGFR as a clinical marker in glioblastomas and other gliomas[J]. Int J Biol Markers, 2018, 33(1): 22-32. doi: 10.5301/ijbm.5000301.
[39] Stichel D, Ebrahimi A, Reuss D, Schrimpf D, Ono T, Shirahata M, et al. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma[J]. Acta Neuropathol, 2018, 136(5): 793-803. doi: 10.1007/s00401-018-1905-0.
[40] Hung A L, Garzon-Muvdi T, Lim M. Biomarkers and Immunotherapeutic Targets in Glioblastoma[J]. World Neurosurg, 2017, 102: 494-506. doi: 10.1016/j.wneu.2017.03.011.
[41] Sun H, Sun Y. Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 2866-2874. doi: 10.1080/21691401.2019.1636807.
[42] Xia W, Wang L, Yu D, Mu X, Zhou X. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis[J]. Mol Med Rep, 2019, 20(2): 1333-1342. doi: 10.3892/mmr.2019.10363.